SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038017
Filing Date
2023-08-03
Accepted
2023-08-03 16:17:36
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lbph-20230630.htm   iXBRL 10-Q 2943486
2 EX-10.1 lbph-ex10_1.htm EX-10.1 42218
3 EX-31.1 lbph-ex31_1.htm EX-31.1 22845
4 EX-31.2 lbph-ex31_2.htm EX-31.2 22888
5 EX-32.1 lbph-ex32_1.htm EX-32.1 22489
6 GRAPHIC img9517409_0.jpg GRAPHIC 58124
  Complete submission text file 0000950170-23-038017.txt   11427749

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lbph-20230630_cal.xml EX-101.CAL 39190
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lbph-20230630_def.xml EX-101.DEF 168897
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20230630_lab.xml EX-101.LAB 415640
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20230630.xsd EX-101.SCH 43720
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20230630_pre.xml EX-101.PRE 309195
54 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20230630_htm.xml XML 2842145
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40192 | Film No.: 231140305
SIC: 2834 Pharmaceutical Preparations